Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
36 participants
OBSERVATIONAL
2019-01-05
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Application of Serial Body Composition Change for Risk Prediction in Treating Patients With Severe Pneumonia
NCT04396522
Body Composition Study in Critically Ill Patients
NCT04262531
Relation Between Bioelectrical Impedance Analysis (BIA) and CT-scan Analysis in the ICU
NCT02555670
Body Composition Study in Critically Ill Patients-Extended to COVID-19
NCT04849624
Body Impedance Analysis to Detect ICUAW
NCT05572138
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BIA and DXA
Patients with acute pneumonia measured simultaneously with DXA-scan and BIA-impedance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Accept participation (informed consent)
* Understand the given instructions and information
Exclusion Criteria
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hillerod Hospital, Denmark
OTHER
Jens Rikardt Andersen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jens Rikardt Andersen
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jens R Andersen, MD,MPA
Role: PRINCIPAL_INVESTIGATOR
University of Copenhagen, Department of Nutrition, Exercise and Sports
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hillerød Hospital
Hillerød, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Daniel1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.